InvestorsHub Logo
Followers 131
Posts 29747
Boards Moderated 0
Alias Born 12/21/2008

Re: LiquidateNow post# 72217

Friday, 11/18/2011 6:13:29 PM

Friday, November 18, 2011 6:13:29 PM

Post# of 105534
Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
Date : 11/17/2011 @ 5:02AM
Source : PR Newswire
Stock : Cord Blood America (CBAI)




Cord Blood America Announces DTCC Removes "Chill" Imposed in December 2010
PrintAlert
Cord Blood America (OTCBB:CBAI)
Intraday Stock Chart
Today : Friday 18 November 2011
Cord Blood America, Inc. (www.cordblood-america.com) (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today is pleased to announce that it has been notified by The Depository Trust & Clearing Corp. that the "chill" announced by the DTCC in December 2010 has been removed.

About Cord Blood America

Cord Blood America is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc., visit our website at http://www.corcell.com/. For investor information, visit http://www.cordblood-america.com/.

Forward-Looking Statements

Some statements made in this press release are forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. We use words such as "anticipate," "believe," "expect,'' "future," "intend," "plan," and similar expressions to identify forward-looking statements. These statements including those related to the growth of the industry, new stem cell treatments, and Cord Blood America's performance, are only predictions and are subject to certain risks, uncertainties and assumptions. Additional risks are identified and described in the Company's public filings with the Securities and Exchange Commission. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company's past performance is not necessarily indicative of its future performance. The Company does not undertake, and the Company specifically disclaims any obligation to update any forward-looking statements to reflect occurrences, developments, events, or circumstances after the date of such statement.

CONTACT:Paul KnopickE & E Communications949/707-5365pknopick@eandecommunications.com

SOURCE Cord Blood America, Inc.


Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.